Drugs

M2: eCTD Specification Questions & Answers and Change Requests Companion Document

This guidance represents the Food and Drug Administration's (FDA's) current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. You can use an alternative approach if the approach satisfies the requirements of the applicable statutes and regulations. If you want to discuss an alternative approach, contact the FDA staff responsible for implementing this guidance. If you cannot identify the appropriate FDA staff, call the appropriate number listed on the title page of this guidance.

U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
Center for Biologics Evaluation and Research (CBER)

ICH

Companion Document

See Document Change History for version and date

Page Last Updated: 03/03/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.